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ABSTRACT 
 
Approximately half of all women in industrialized countries will experience urinary 
incontinence during their lifetime. Even though urinary incontinence is not a life 
threatening disease, it often has severe implications for daily function, social 
interactions, sexuality and psychological well-being. Moreover, urinary incontinence 
has a major impact on health economy and is increasingly recognized as a global health 
burden. Hence, identifying risk factors for urinary incontinence is of importance for 
individual women at risk, as well as for society’s health care costs.  
 
In the first study, the association between coffee and tea intake and urinary 
incontinence was evaluated. Women with a high coffee intake were at lower risk of 
overall incontinence, while no effect was observed between coffee intake and other 
urinary incontinence subtypes. A higher risk of nocturia and overactive bladder was 
found among women with a high tea intake. However, results from co-twin control 
analysis showed that these associations were likely confounded by familial factors. 
 
 In the second study, the effect of gestational diabetes mellitus on overactive 
bladder was investigated. Women with gestational diabetes mellitus had an almost two 
times higher odds of overactive bladder compared to women without gestational 
diabetes. The effect of gestational diabetes mellitus on overactive bladder was not 
mediated by body mass index or diabetes later in life.  
 
In the third study, the association between depressive mood disorders (depressive 
symptoms and major depression) and neuroticism with urinary incontinence was 
investigated. In logistic regression analysis depressive mood disorders and neuroticism 
were positively associated with urinary incontinence. Results from quantitative genetic 
analysis showed that the association between depressive mood disorders, neuroticism 
and urinary incontinence was partly determined by genetic factors in common to the 
disorders. 
 
In the fourth study, the effect of birth weight and being born small for gestational 
age on urinary incontinence later in life was evaluated. Results showed that birth 
weight and being born small for gestational age had no effect on urinary incontinence. 
However, women who had a low birth weight and then became overweight had a 
borderline statistically significant higher odds of overall and stress incontinence 
compared to overweight women who had a normal birth weight. This finding suggests 
that low birth weight in combination with elevated adult body mass index may 
contribute to the risk of urinary incontinence later in life. 
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1 INTRODUCTION  
 
The prevalence of urinary incontinence in women is relatively low early in life, has a 
peak around the time of menopause, and then rises steadily between the ages of 60 to 
80 years.1 Epidemiological studies suggest that urinary incontinence has an overall 
prevalence of 25-45% in adult women.2  
Even though urinary incontinence is not a life threatening disease, it often has 
severe implications on daily function, social interactions, sexuality and psychological 
well-being. Moreover, urinary incontinence has a major impact on health economy and 
is increasingly recognized as a global health concern.3 For example, it has been 
estimated that the cost for the society associated with urinary incontinence in the USA 
for year 2000 was close to 20 billion dollars.4 Hence, identifying risk factors for urinary 
incontinence is of importance for women at risk, as well as for society’s health care 
costs.  
Recent data from twin studies suggest that familial factors such as common genes 
and shared environment may influence the occurrence of urinary incontinence.5-8 It is 
therefore of importance to also investigate whether common genes and shared 
environmental factors are confounding the association with potential risk factors. For 
this purpose, twin data can be used to disentangle genetic from environmental effects 
and provide important clues to the etiology of female urinary incontinence. 
This thesis builds on four studies (Study I-IV), all based on the Study of Twin 
Adults: Genes and Environment (STAGE),9 a web-based survey performed in 2005 
among all Swedish twins born between 1959 and 1985 that contained questions 
regarding common complex diseases and common exposures. The aim of these four 
studies was to evaluate the effect of potential risk factors for urinary incontinence and 
other lower urinary tract symptoms, such as nocturia and overactive bladder, using data 
from a cohort of premenopausal female twins.  
 2 
2 BACKGROUND 
 
2.1 CONTINENCE IN WOMEN  
Continence in women is obtained through a complex coordination between the bladder, 
urethra, pelvic muscles, and surrounding connective tissues. The bladder is an elastic 
muscular organ located on the anterior surface of the uterus responsible for the storage 
and collection of urine excreted by the kidneys before disposal through urination. The 
middle layer of the bladder wall consists of smooth musculature, forming the detrusor 
muscle, whereas the inner and outer muscle layers consist of striated muscle fibers. 
Maximum bladder capacity is typically in the range of 500–600 mL, however, the 
bladder is capable of increasing the urinary volume without increasing bladder 
pressure. In infants, bladder fullness produces a contraction of the detrusor muscle that 
empties the bladder. In response to bladder training, we learn to control the sensation of 
urge when the bladder volume is approximately 200–300 mL and then decide whether 
the time and place for voiding is appropriate. 
 
The female urethra is an approximately 3.5 cm long and 6 mm wide fibro muscular 
tube that connects the bladder reservoir to the body surface. The main role of the 
urethra is to maintain a sufficient pressure in order to prevent an involuntary loss of 
urine in situations in which the pressure may increase, such as sneezing, coughing or 
physical activity. The urethra is surrounded by both skeletal and smooth muscles that 
contribute to resting tone, but only skeletal muscle responds when the abdominal 
pressure increases.10 
 
The muscles of the pelvic floor, particularly the levator ani muscles, have a critical role 
in supporting the pelvic visceral organs and play a major role in urinary, defecatory, 
and sexual function. The levator ani muscle has a three-dimensional structure in which 
its anterior portion (pubococcygeus and puborectalis) is oriented vertically as a sling 
around the mid-urethra, vagina, and anorectum (Figure 1). Instead the posterior portion 
of the levaror ani, the iliococcygeus, has a horizontal upwardly biconvex shape. While 
the posterior portion of the levator ani serves as a supportive diaphragm, the anterior 
portion serves to close the urogenital hiatus and pull the urethra, vagina, perineum, and 
anorectum toward the pubic bone. This upwards movement of the levator ani creates a 
backstop for the whole urinary tract that compresses the two walls of the urethra and 
prevents an involuntary loss of urine when the abdominal pressure rises.10 
 
When voiding begins, the urethra relaxes in order to allow the urine to pass through and 
then the spinal reflex pathways are activated.11 An increase in parasympathetic 
transmissions to the bladder causes a contraction of the detrusor muscle. These same 
pathways inhibit sympathetic and pudendal outflow to the urethra, maintaining also the 
urethra relaxed. Detrusor contraction increases the intravesical pressure sufficiently to 
empty the bladder. 
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c) Puborectalis 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted with permission from Ethicon US. 
Many aspects of the continence mechanism are not fully understood. These include the 
relation between anatomical support and function and the ability of the continence 
mechanism to adapt and repair after childbirth, pelvic surgery or neurological injury. 
 
2.2 URINARY INCONTINENCE 
Urinary incontinence indicates an involuntary loss of urine and is generally more 
common among women rather than in men. Women of all ages may be affected by 
urinary incontinence and its prevalence usually increases with age; moreover urinary 
incontinence is characterized by a wide range of severity and nature of symptoms. The 
prevalence of urinary incontinence depends also by the definition in use: while some 
studies used daily incontinence to define women affected by urinary incontinence, 
others used a weekly, monthly, or even a yearly occurrence to define incontinence. 
 
 
2.2.1 Urinary incontinence subtypes  
Urinary incontinence is usually classified as stress, urge, and mixed urinary 
incontinence.  Stress incontinence involves the involuntary loss of urine that occurs 
during physical activity or suddenly increased abdominal pressure, for example 
coughing, sneezing, laughing, or physical exercise. The main identified disorders 
related to stress incontinence are impaired mid-urethral support and intrinsic sphincter 
deficiency.12 This means that stress urinary incontinence may occur if the urethral 
sphincter does not work properly or if the pelvic floor muscles, that support the urethra 
and the bladder, are weakened. When this happens, the sphincter is not able to maintain 
urine inside the bladder when the abdominal pressure suddenly increases causing a 
leakage of urine. 
 
Another urinary incontinence subtype is urge incontinence, which is a loss of urine that 
is accompanied by a sudden need to urinate. The pathophysiology of urge incontinence 
Figure 1. The levator ani muscles of the female pelvic floor. 
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is less clear than the pathophysiology of stress urinary incontinence. Urge incontinence 
usually is caused by the bladder that contracts too often because of some neurological 
problems or bladder irritation: it seems to be connected with poor transmission or 
processing of information between the bladder and the nervous system.13 
 
Women affected by both stress and urge urinary incontinence are defined as having 
mixed urinary incontinence, while women with either stress or urge urinary 
incontinence are defined as having overall urinary incontinence. 
 
The prevalence of urinary incontinence is relatively low early in life, has a peak around 
the time of menopause, and then rises steadily between the ages of 60 to 80 years.1 
Overall, approximately half of all women with incontinence are defined as having 
stress urinary incontinence. A smaller proportion of women are affected by urge and 
mixed urinary incontinence. A previous study performed among women of all ages 
have shown that stress incontinence reaches its peak for the 40-49 year old age group 
and then decreases, while mixed urinary incontinence increases regularly with age.14 
 
 
2.2.2 Overactive bladder 
Overactive bladder is a symptom based disorder, which has been defined as ‘urinary 
urgency, with or without urgency incontinence, usually with frequency and nocturia’ by 
the International Continence Society (ICS).15 Overactive bladder causes a sudden need 
to urinate which is hard to control, and may result in the subsequent involuntary loss of 
urine. However, women might be affected by overactive bladder even if they do not 
experience an involuntary loss of urine since the complex symptom of overactive 
bladder is characterized by other symptoms such as frequency (i.e. women urinate more 
frequently) and nocturia, which is the complaint that women have to wake up several 
times at night to urinate. 
 
Figure 2. Definition of overactive bladder.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urge 
incontinence  Urinary  
frequency 
Urinary 
urgency  
Nocturia 
“Urinary urgency, with or 
without urge incontinence, 
usually with increased 
frequency of micturition  
and nocturia, which are not 
explained by metabolic or  
local pathologic factors” 
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Another prerequisite for the conditions of overactive bladder to be fulfilled is that 
symptoms are not explained by metabolic or local pathologic factors such as urinary 
tract infections, bladder tumors, or bladder stones which may give rise to symptoms 
that mimic overactive bladder. 
 
Overactive bladder is a common condition. A study performed among community-
dwelling adults living in five industrialized countries (Canada, Germany, Italy, Sweden, 
and the United Kingdom), reported that the overall prevalence of overactive bladder 
was approximately 12 percent.16 Moreover, it has been estimated that 33 million people 
in the US are affected by overactive bladder.17  
 
 
2.2.3 Effect of urinary incontinence on women and cost for the society 
Lower urinary tract symptoms (LUTS) such as urinary incontinence and overactive 
bladder might have a tremendous impact on quality of life. Previous studies reported 
that the occurrence of urinary incontinence is negatively associated with quality of 
life.18 19 It has been shown that the negative impact of overactive bladder on quality of 
life is greater than diabetes.3 The presence of urinary incontinence or overactive bladder 
might generate feelings of sadness, anger, and embarrassment. Moreover, women with 
incontinence may lose self-confidence, avoid physical exercise and social gatherings. 
This could in turn affect sexual life, social interactions, emotional health, and quality of 
sleep.20-22  
 
Even though urinary incontinence and overactive bladder are common conditions, 
many women with incontinence never report their symptoms to their general 
practitioners. Several studies have reported that the proportion of women affected by 
incontinence who have sought treatment in the past 12 months ranged between 12%-
53%.2 Women with urge or mixed incontinence are more likely to seek treatment: in 
fact an overactive bladder is more difficult to control since it will more likely interrupt 
sleep or other daily activity. Women with severe or daily incontinence are also more 
likely to seek treatment. However even among women with severe incontinence 
seeking treatment can be relatively low: a study performed among women with daily 
UI found that only half of them had ever reported their symptoms to their healthcare 
providers.23 Women do not seek treatment for urinary incontinence mainly because of 
embarrassment. Other reasons for not seeking treatment are: the idea that incontinence 
is not a disease but only a normal part of ageing, low expectations of treatment, and 
thinking that they should cope on their own.2  
 
Another important aspect of lower urinary tract symptoms, such as urinary 
incontinence and overactive bladder, is the cost for the society. It has been estimated 
that in the US the cost for the health care system associated with urinary incontinence 
and overactive bladder for year 2000 was respectively $ 19.5 billion and $ 12.6 billion.4 
Even if overactive bladder is more common than strict urinary incontinence, the lower 
costs associated with this condition are mainly determined by the fact that individuals 
affected by overactive bladder, but without incontinence, incurred in lower costs 
compared to individuals with incontinence. Already in 1999 Statens beredning för 
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utredning av hälso-och sjukvården (SBU) estimated that the nationwide annual costs 
for the direct care of stress urinary incontinence in Sweden exceeded 5 billion SEK. 
Moreover, from 2000 to 2007 in Sweden there was a 68.8% increase in dispensed 
anticholinergic drugs, a medication used to treat overactive bladder symptoms, while 
the Swedish population increased only by 3.4% (Figure 2) In 2007 the annual direct 
cost for anticholinergic drugs in Sweden was 22 million €.24 Given the ageing of the 
population and the fact that urinary incontinence is very common among the elderly, it 
is expected that the costs associated with urinary incontinence and overactive bladder 
will further increase in the future. 
 
Figure 3. Prescription of anticholinergic drugs per annum in relation to the total 
population 
 
 
 
 
2.3 ESTABLISHED RISK FACTORS FOR URINARY INCONTINENCE 
 
2.3.1 Age 
Almost every epidemiological study reports a positive association between urinary 
incontinence and age. The prevalence of urinary incontinence increases with age until 
middle age, remains stable until the age of 70, and then rapidly increases among the 
elderly.2 Women may remain continent as long as they are able to compensate the 
effects of ageing, such as lower intrinsic lower pressure, by using other components of 
the continence mechanism. However with ageing, women might lose pelvic floor 
muscle strength and connective tissue resilience and become incontinent. Another 
explanation is that with ageing, women are more likely to be affected by medical 
problems or conditions associated with urinary incontinence, such as diabetes mellitus, 
cognitive impairment, connective tissue disorders and physical disability.2 
 
 
   7 
2.3.2 Childbirth, pregnancy, and parity 
Many studies have reported a positive association between parity and urinary 
incontinence later in life.2  While some studies have reported that after the first delivery 
there is a little or no additional effect of subsequent deliveries,26 27 others have shown 
that with increasing parity the risk of incontinence increases as well.27 28 The 
association between parity and urinary incontinence relates primarily to stress and 
mixed urinary incontinence while several studies have found that in the long term there 
is no association between parity and urge urinary incontinence.28-30 During pregnancy 
most women are affected by stress urinary incontinence to some extent, particularly 
during the third trimester. After childbirth, continence returns in most women while for 
others incontinence persists even after the delivery.31 32 Moreover, women who were 
affected by incontinence during pregnancy are at higher risk of developing urinary 
incontinence later in life, even if they became continent after childbirth.33 34  
 
One possible explanation for the association between parity and incontinence is 
obstetrical trauma which over time and ageing could lead to urinary incontinence. 
Childbirth may damage or weaken pelvic floor muscles, disrupt or traumatize bladder 
and urethral innervation, and injure supportive structures such as pubocervical fascia 
which may cause future incontinence. Studies have shown that vaginal delivery causes 
an increased pudendal nerve terminal latency and urethral mobility, perineal descent, 
widening of the levator hiatus, and levator avulsion.35-37 Moreover, observational 
studies have reported that the prevalence of stress incontinence is higher among women 
who had vaginal delivery compared to women who had a cesarean section.29 38 39 
  
However, the importance of obstetrical trauma has been put into question.40 A study 
has shown that the highest prevalence of stress urinary incontinence is not postpartum, 
but rather in the prenatal stage (i.e. during the last trimester).41 Another study reported 
that 12 months after the delivery, there is a substantial remission of stress urinary 
incontinence: in the postpartum period the prevalence of stress urinary incontinence is 
19% and after one year it is reduced to 3%.42 Moreover, even though observational 
studies seems to support the obstetrical trauma hypothesis, the protective effect of 
cesarean section, compared to vaginal delivery, can partly be explained by selection 
bias. Women who delivered by cesarean section might differ from women who had a 
vaginal delivery in respect to age, parity, and body mass index.29 
 
Another explanation for the association between parity and urinary incontinence is that 
the physiological changes that occur in women during pregnancy may lead to 
incontinence later in life. Weight gain during pregnancy could explain the higher 
prevalence of stress incontinence during pregnancy and the subsequent remission after 
the delivery.40 Moreover, hormonal and metabolic modifications that occur during 
pregnancy may lead to urinary incontinence later in life.40 
 
 
2.3.3 Body mass index 
Body mass index is another well-established risk factor for urinary incontinence. 
Studies have reported an association between body mass index and all types of 
incontinence (i.e. stress, urge and mixed urinary incontinence).27 43 44 The association 
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increases in strength with increasing body mass index and obese women have the 
highest risk of incontinence: women in the highest quartile of body mass index are 2-4 
times more likely to have incontinence compared to women in the lowest quartile. 
Evidence of the fact that body mass index is a risk factor for urinary incontinence 
comes also from longitudinal studies, where it has been shown that an increase in body 
weight, or in body mass index, is associated with a higher risk of incontinence.45 46 
Body mass index is a modifiable risk factor for urinary incontinence: studies have 
shown how weight reduction among incontinent women may be beneficial and could 
lead to incontinence remission.47-49 
 
One possible explanation for this association is that overweight and obesity increases 
the intra-abdominal pressure and, with time, may weaken the pelvic floor muscles and 
the structures that support the urethra and the bladder. As mentioned previously, an 
increased abdominal pressure, a weakening of the pelvic floor muscles or a non-
sufficient support of both the urethra and bladder might lead to an involuntary loss of 
urine. To support this hypothesis, studies have shown that waist to hip ratio is more 
strongly associated with stress incontinence than body mass index.45 50 However, the 
fact that body mass index is associated with both stress and urge incontinence, suggests 
that there might be other mechanisms by which body mass index leads to urinary 
incontinence.  
 
 
2.4 POTENTIAL RISK FACTORS FOR URINARY INCONTINENCE 
 
Age, parity, and an elevated body mass index are well established risk factors for 
urinary incontinence. However, other factors may cause urinary incontinence in 
women.  
 
2.4.1 Coffee and tea 
Coffee and tea are two of the most consumed beverages in the Western world. Both 
these beverages contain caffeine, a stimulant drug, but the amount of caffeine contained 
in tea is usually one third of that in coffee.51  
 
Previous studies regarding the association between coffee and tea consumption are 
conflicting: while some studies reported a positive association between caffeine intake 
or coffee and tea consumption,52-54 others found no association.44 55-57 One of the 
possible effect of caffeine on the lower urinary tract is that it may decrease the closure 
pressure of the urethra58: a lower closure pressure of the urethra could lead to an 
involuntary loss of urine particularly after an increase in the abdominal pressure, caused 
for example by sneezing or coughing. A previous study reported that women affected 
by overactive bladder responded to drinking caffeine citrate by an excitatory effect on 
the detrusor smooth muscle during the bladder filling phase.52  
 
Population based studies failed to report a positive association between coffee 
consumption and urinary incontinence.44 55 56 The study by Hannestad et al.,44 found no 
effect of coffee intake on urinary incontinence, while a positive association between tea 
consumption and urinary incontinence was reported. Instead another study found no 
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effect of tea intake and a protective effect of coffee consumption, although not 
statistically significant.56 Moreover, a randomized crossover study performed among 
women with urodynamically proven stress incontinence or idiopathic detrusor 
overactivity to determine the effect of caffeine restriction and fluid manipulation found 
that changing from caffeine containing to decaffeinated drinks produced no 
improvement in urinary symptoms.57 
 
Despite the conflicting results, caffeine restriction is an internationally accepted 
treatment strategy for patients with urinary incontinence. 
 
 
2.4.2 Gestational diabetes mellitus 
Observational studies reported that urinary incontinence and overactive bladder are 
overrepresented among women with type 1 and type 2 diabetes mellitus.59-63 The 
mechanisms by which diabetes could lead to urinary incontinence or overactive bladder 
in women are not clear, but different mechanisms have been suggested such as 
peripheral neuropathy, microvascular complications, decreased production of nerve 
growth factor in the bladder, and changes of nitric oxide regulation in the 
uroepithelium.64 65 Many studies have investigated the association between diabetes 
mellitus and urinary incontinence; however very few studies have looked at the effect 
of gestational diabetes mellitus (GDM) on incontinence.66 67  
 
Gestational diabetes mellitus is defined as carbohydrate intolerance resulting in 
hyperglycaemia, with first onset or detection during pregnancy.68 GDM often debuts 
during the second trimester due to physiological changes in glucose metabolism and a 
gradual increase in insulin resistance, and is considered an established risk factor for 
diabetes type 2 later in life.69 It has been estimated that gestational diabetes mellitus 
affects 2-6% of the pregnancies in Europe.70 The prevalence of GDM depends on the 
population being studied and the diagnostic test utilized: there are no universally 
accepted diagnostic criteria for GDM and the prevalence of GDM in Northern Europe 
is mostly below 4% while in Southern Europe is above 6%.70    
 
The main risk factors for GDM are advanced maternal age, family history of type 2 
diabetes, being overweight or obese, and a previous diagnosis of GDM. In fact women 
may have gestational diabetes mellitus several times, even at each pregnancy. 
 
Only two studies have evaluated the association between GDM and urinary 
incontinence. A cross sectional study performed among 228 women with GDM 
reported that stress urinary incontinence was common, with almost 50% of these 
women reporting weekly incontinence after the delivery.15 However, in this study there 
was no control group (i.e. a group of women without GDM). A prospective study 
performed in Taiwan reported that women with GDM had a 2-3 times higher odds of 
stress, urge, and mixed incontinence compared to women with normal glucose level 
during pregnancy.66 67   
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2.4.3 Major depression and neuroticism 
Other potential risk factors for urinary incontinence are major depression and 
neuroticism. 
 
Major depression is a mental disorder characterized by episodes of low mood 
accompanied by low self-esteem and loss of interest in normally enjoyable activities. 
The prevalence of depression varies across different age groups but, on average, one 
out of five women will experience depression during their lifetime71: the most common 
time of onset is between the ages of 20 and 30 years. 
 
Several studies, mainly cross-sectional, have found a positive association between 
major depression and urinary incontinence.72-75 Different theories have been proposed 
to explain this association. The first theory claims that the increased activity of the 
hypothalamic-pituitary axis observed among depressed subjects may cause urinary 
incontinence. A second hypothesis proposes that the social isolation and the chronic 
embarrassment associated with urinary incontinence could lead to depression. A third 
theory suggests that urinary incontinence and depression are associated because they 
share a common biochemical or neurologic pathways: it has been suggested that a 
reduced serotonin function could predispose to both depression and bladder 
overactivity.74 75 Two prospective studies have evaluated the temporality of the 
association between depression and incontinence.76 77 While the first study used 
medical diagnosis of urinary incontinence and depression, the second study used self-
reported information to evaluate whether women with depression at baseline had a 
higher risk of incontinence later in life and vice versa. Both studies found that women 
with depression at baseline are at higher risk of developing incontinence later in life. 
Instead no increased risk of depression among women with urinary incontinence at 
baseline was observed. 
 
Contemporary psychology uses five personality traits to describe the human 
personality: openness, conscientiousness, extraversion, agreeableness, and neuroticism 
(also called emotional instability). Individuals who are emotionally unstable are more 
likely than the average to experience such feelings as anxiety, anger, envy, guilt, and 
depressed mood. Few studies have evaluated the association between neuroticism and 
incontinence in women: these studies have shown that women with UI tend to score 
higher on the neuroticism scale compared to women without incontinence. 78 79 
 
 
2.4.4 Birth weight and being born small for gestational age 
Previous studies have shown that birth characteristics such as being born small for 
gestational age (SGA) and low birth weight (LBW) are associated with adult disorders 
such as type 2 diabetes, hypertension and coronary heart disease.80-84  
 
According to the developmental origins of adult disease and health, a stimulus or insult 
during a sensitive period of development has lasting effects on the structure or function 
of the body.85 Poor intrauterine nutrition is an example of a stimulus that may influence 
the development of the fetus; in fact the fetus reacts to a lower maternal nutrition by 
reducing its body size and by developing insulin resistance. If reduced maternal 
nutrition is a stimulus that correctly predicts the external environment, then a reduced 
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body size and insulin resistance may provide better chance of survival to the baby after 
the delivery. However, when the baby expects to face a harsh environment but instead 
finds himself in an environment where food is abundant there is a mismatch. This 
mismatch between the “in utero” predicted and the actual environment may predispose 
these individuals to certain diseases later in life.86 87  
 
In the literature there are no studies that have evaluated the effect of birth 
characteristics on the risk of developing urinary incontinence, however it is possible 
that women who were growth restricted are at higher risk of incontinence. Previous 
studies, performed in both animals and humans, have shown that maternal nutritional 
restriction and low birth weight affect the number and composition of skeletal muscle 
fibers88-92 and also muscle strength in the offspring.93-97 As a consequence, women with 
an impaired muscle development caused by intrauterine growth restriction could have 
weaker pelvic floor and detrusor muscles and therefore carry a higher risk of lower 
urinary tract dysfunction later in life, such as urinary incontinence.  
 
 
2.4.5 Other potential risk factors 
For many years oral estrogen replacement therapy has been widely used to treat urinary 
incontinence during or after menopause. However, results from a large placebo-
controlled randomized trial of estrogen replacement therapy showed that women taking 
estrogen were more likely to experience worsening of their incontinence.98 99 Moreover, 
the Women´s Health Initiative Hormone Replacement Trial found that women 
receiving estrogen were twice more likely to develop stress urinary incontinence after 
one year.100 
 
Hysterectomy is another factor that may be associated with urinary incontinence via 
damage to the pelvic nerves and pelvic supportive structures. Several epidemiologic 
studies have reported a weak or moderate association between a history of 
hysterectomy and current urinary incontinence.2 However, prospective studies 
regarding the effect of hysterectomy on incident incontinence showed conflicting 
results. Only one prospective study reported a positive association between a history of 
hysterectomy and urinary incontinence,101 while two prospective studies found no 
association.102 103 
 
Cross sectional studies have found that women with urinary incontinence are more 
likely to have a history of urinary tract infections (UTI).2 However, UTIs are often 
diagnosed based on symptoms rather than culture confirmation. Therefore it is possible 
that some women may receive an erroneous diagnosis of urinary tract infection instead 
of urge incontinence. A prospective study of women aged 55-75 found that the baseline 
prevalence of urinary incontinence was two times higher among women who later 
develop a UTI.104 Based on the current research, it is not possible to determine whether 
UTIs increase the risk of urinary incontinence or vice versa.  
 
Results regarding the effect of smoking on urinary incontinence are conflicting.2 An 
increased intra-abdominal pressure due to increased coughing among smokers could 
explain the association between smoking and urinary incontinence. The Nurses´ Health 
Study II found that smoking is a weak risk factor for incontinence,105 while other four 
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prospective cohort studies found no association between smoking and incident urinary 
incontinence.102 103 106 107 
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3 AIMS 
 
The overall aims of this thesis were to evaluate the association between urinary 
incontinence and potential risk factors using data from a cohort of premenopausal 
female twins and to investigate the contribution of genetic and shared environmental 
factors to these associations.  
 
The specific aims were: 
 
• To study the association between two of the most consumed beverages 
containing caffeine (coffee and tea) and urinary incontinence, and to evaluate 
the role of familial factors to these associations (Study I) 
 
• To study the association between gestational diabetes mellitus and overactive 
bladder among parous women (Study II) 
 
• To study the association between urinary incontinence, depressive mood 
disorders (depressive symptoms and major depression), and neuroticism and to 
quantify the genetic contribution to the correlation between these traits (Study 
III) 
 
• To study the effect of birth characteristics, such as birth weight and being born 
small for gestational age, on urinary incontinence (Study IV) 
 
 14 
4 STUDY POPULATION AND REGISTERS 
 
4.1 THE SWEDISH TWIN REGISTRY  
The Swedish Twin Registry (STR) is one of the world’s largest twin resources and 
currently contains information on more than 194,000 twins. The registry was 
established in the 1950’ to investigate the role of smoking and alcohol consumption on 
cancer and cardiovascular diseases, allowing researchers to take into account the effect 
of genetic factors. The registry is regularly updated with information obtained from the 
Swedish health registers. However, the health registers are not the only sources of 
information available: the twins have also been contacted to participate in survey 
studies, answering to questionnaires, sometimes repeatedly, covering a selection of 
common complex diseases and exposures. Among the twin pairs in the STR, zygosity 
has been determined for approximately 75 000 pairs using questions about intra-pair 
physical similarities in childhood. Tests of the validity of using self-reported 
information regarding similarity in zygosity assignment have found an accuracy 
estimate of approximately 98%.108 109  
 
 
4.2 STUDY OF TWIN ADULTS: GENES AND ENVIRONMENT (STAGE) 
In 2005, all Swedish twins born between 1959 and 1985 were invited to participate to 
the Study of Twin Adults: Genes and Environment (STAGE), a web-based survey 
containing approximately 1,300 questions regarding common complex diseases and 
exposures relevant during adulthood and midlife.9 Participants had the possibility to 
perform a telephone interview, rather than the web-survey, if they preferred. The 
questionnaire contained 34 sections presented in a branching format, meaning that 
individuals had to reply to follow-up questions only if they responded positively to the 
introductory questions.  
 
There were a total of 42,825 eligible twins and the total response rate was 59.6%. 
Almost fifty percent of the women contacted filled in the web-survey (49.9%) and an 
additional 16% completed a telephone interview. To assess test-retest reliability and to 
evaluate if there was a difference between the web questionnaire and the telephone 
interview, one hundred twins were recontacted after two months. Cohen's kappa values, 
a measure of concordance, were moderate, good, or excellent for most of the 
conditions: this finding indicates that it was possible to combine data from the two 
different sources.9  
 
STAGE was the main source of information for the four studies of this thesis. 
Information regarding coffee and tea consumption (Study I), gestational diabetes 
mellitus (Study II), depressive symptoms, major depression, and neuroticism (Study 
III), birth weight (Study IV), urinary incontinence as well as information about possible 
confounding variables (body mass index, parity, educational level, and smoking status) 
was obtained from the survey. However, the Medical Birth Register has been used in 
Study II to collect additional information regarding gestational diabetes mellitus 
   15 
diagnosis and in Study IV to obtain information about birth characteristics (birth 
weight, birth order, gestational age etc.) for the twins born between 1973 and 1985.  
 
The Medical Birth Register (MBR) was established in 1973 and contains information 
about antenatal, obstetrical, and neonatal care for approximately 98% of the births that 
have occurred in Sweden.110 For twins born between 1959 and 1972, birth 
characteristics have been obtained from original birth records stored in medical 
archives. 
 
 
4.3 OUTCOME AND EXPOSURES DEFINITION 
4.3.1 Urinary incontinence subtypes and overactive bladder 
In this thesis, four urinary incontinence subtypes (overall, stress, urge, and mixed 
urinary incontinence) and other two lower urinary tract symptoms (nocturia and 
overactive bladder) have been analyzed. These definitions were based on 
recommendations from the International Continence Society111 and referred to the 30-
day period preceding the survey (Table 1). 
 
Table 1. Definition of lower urinary tract symptoms based on recommendations from 
the International Continence Society 
Lower urinary tract symptom Definition Questions in STAGE 
Overall UI Complaint of involuntary loss of 
urine 
Do you have present 
involuntary loss of urine? 
Stress UI Complaint of involuntary loss of 
urine on effort or physical exertion 
(e.g., sporting activities), or on 
sneezing or coughing. 
Do you have involuntary 
loss of urine in connection 
with coughing, sneezing, 
laughing, lifting heavy 
items? 
Urge UI Complaint of involuntary loss of 
urine associated with urgency 
Do you have involuntary 
loss of urine in connection 
with a sudden and strong 
urge to void? 
Mixed UI Complaint of involuntary loss of 
urine  associated with urgency and 
also with effort or physical exertion 
or on sneezing or coughing 
A positive response to the 
question on stress and urge 
UI 
Nocturia Complaint of interruption of sleep 
one or more times because of the 
need to micturate 
“Do you urinate at least 
twice per night?” 
Overactive bladder Urinary urgency, usually 
accompanied by frequency and 
nocturia, with or without urge 
urinary incontinence 
“Do you experience sudden 
urgency to void with little or 
no warning?” or “Do you 
have involuntary loss of 
urine in connection with 
sudden and strong urgency 
to void?” 
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From a questionnaire it is possible only to evaluate the presence of urinary incontinence 
symptoms rather than performing a clinical diagnosis of urinary incontinence. Sandvik 
and coauthors validated these diagnostic questions against a final diagnosis made by a 
gynecologist after urodynamic evaluation: they found that the prevalence of women 
with stress incontinence was underestimated while mixed incontinence was 
overestimated. Instead the number of women affected by urge incontinence remained 
virtually the same.111 
 
 
4.3.2 Exposures definition 
Coffee and tea 
In Study I the exposures of main interest were daily consumption of coffee and tea. 
Study participants were asked to report the number of cups of coffee and tea that they 
usually drink every day. This information has been categorized in three groups: zero 
cups, one or two cups, three or more cups per day. 
 
Gestational diabetes mellitus 
The aim of Study II was to investigate the association between overactive bladder and 
gestational diabetes mellitus. Information about the occurrence of gestational diabetes 
mellitus in the past was obtained from the STAGE survey. Additional information 
regarding gestational diabetes mellitus was obtained from the Medical Birth Register 
using ICD-9 codes 648A and 648W and ICD-10 codes O24.4–O24.5.  
 
Depressive symptoms 
The presence of depressive symptoms in the week preceding the survey was defined 
using the Center for Epidemiological Studies Depression Scale (CES-D).112 The CES-
D scale is a short self-report scale based on 20 items and designed to estimate the 
current level of depressive symptomatology in the general population. It has been 
shown that CES-D scores discriminate well between psychiatric inpatient and 
individuals from the general population. Seventy percent of the patients had a score 
above the arbitrary cut-off of 16 while in the general population only 21% of the 
individuals had a score greater than 16.112  
 
In the STAGE survey a shorter version of the CES-D scale, based on 11 items, called 
the Iowa form, has been used (Table 2).113 The 11-item Iowa form was used with a four 
point response format (0 = never or almost never, 1 = seldom, 2 = often, 3 = always or 
almost always). Using this inventory, respondents are defined as affected by current 
depressive symptoms if their total score is equal to or greater than 8. The scores for 
questions 5 and 8 have been reversed (3 = never or almost never, 2 = seldom, 1 = often, 
0 = always or almost always) since these two items are worded in a positive direction. 
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Table 2. Items used in STAGE to assess the presence of current depressive symptoms  
During the past week: 
1. I did not feel like eating; my appetite was poor 
2. I felt depressed 
3. I felt everything I did was an effort 
4. My sleep was restless 
5. I was happy 
6. I felt lonely 
7. People were unfriendly 
8. I enjoyed life 
9. I felt sad 
10. I felt that people disliked me 
11. I could not get “going” 
 
Neuroticism 
Neuroticism was defined using a short form of the Eysenck Personality Inventory (EPI-
Q).114 This short version of the questionnaire includes 9 yes/no questions (Table 3). The 
neuroticism score has been determined by adding the numbers of “yes” in the nine 
questions. To distinguish women who score high on the neuroticism scale from women 
with a normal score a cut-off value of 5 can be used (0-4 = low neuroticism, 5-9 high 
neuroticism). 
 
Table 3. EPI-Q questions used in STAGE to assess the neuroticism score 
1. Are you often uneasy, feeling that there is something you want without 
knowing it? 
2. Are you sometimes happy and sometimes sad without any special reason? 
3. Do you often reach decision too late? 
4. Do you often feel tired and listless without any special reason? 
5. Are you often lost in your thoughts? 
6. Are you extremely sensitive in any respects? 
7. Are you ever too restless to sit still? 
8. Do you have any nervous problem? 
9. Do you usually worry a long time after a distressing event? 
 
In all statistical analyses the standardized log transformed scores for both depressive 
symptoms and neuroticism have been used instead of binary indicators in order to 
improve the statistical power particularly for the co-twin control analysis. In the co-
twin control analysis only twin pairs that are discordant for both the outcome and the 
exposure contribute to the likelihood: using the standardized log transformed score 
rather than a binary variable the number of informative twin pairs was increased. 
 
Major depression 
In the STAGE survey, the definition of lifetime major depression was based on DSM-
IV criteria (Table 4) and was measured using the computerized Composite International 
Diagnostic Interview-Short Form (CIDI-SF), which was adapted from its original 
design for 12-month prevalence to assess lifetime prevalence of major depression.115 116 
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Only questions related to criteria A, C, and E were present in the STAGE survey: study 
participants have been classified as affected by at least one episode of depression in the 
past if all these three criteria were present. 
 
Table 4. Major Depressive Disorder DSM-IV Diagnostic Criteria 
Criterion A 
A minimum of five symptoms from the following list have been present during the 
same 2-week period and represent a change from previous functioning. One of the 
symptoms must be #1 or #2, as listed below: 
1) Depressed mood most of the day, nearly every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation made by others (e.g. appears tearful) 
2) Markedly diminished interest or pleasure in all, or almost all, activities most of the 
day, nearly every day, as indicated either by subjective account or observation made by 
others. Do not include symptoms that are clearly due to general medical condition or 
mood-incongruent delusions or hallucinations 
3) Significant weight loss when not dieting or weight gain (e.g. a change of more than 
5% of body weight in a month) or decrease or increase in appetite nearly every day 
4) Insomnia or hypersomnia nearly every day 
5) Psychomotor agitation or retardation nearly every day (observable by others, not 
merely subjective feelings of restlessness or being slowed down) 
6) Fatigue or loss of energy nearly every day 
7) Feelings of worthlessness or excessive or inappropriate guilt (which may be 
delusional) nearly every day (not merely self-reproach or guilt about being sick) 
8) Diminished ability to think or concentrate, or indecisiveness, nearly every day (either 
by subjective account or as observed by others) 
9) Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation 
without a specific plan, or a suicide attempt or specific plan for committing suicide 
Criterion B 
The symptoms do not meet the criteria for a mixed episode 
Criterion C 
The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning 
Criterion D 
The symptoms are not due to the direct physiological effects of a substance (e.g., a drug 
of abuse, a medication) or a general medical condition (e.g., hypothyroidism) 
Criterion E 
The symptoms are not better accounted for by bereavement, i.e., after the loss of a 
loved one, the symptoms persist for longer than 2 months or are characterized by 
marked functional impairment, morbid preoccupation with worthlessness, suicidal 
ideation, psychotic symptoms, or psychomotor retardation 
 
Birth weight and being born small for gestational age 
In Study IV the aim was to evaluate the effect of birth characteristics, such as birth 
weight and being born small for gestational age, on urinary incontinence. Being born 
small for gestational age has been defined as a birth weight below the 10th percentile for 
each gestational age.  
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To obtain information regarding birth weight we used data from the Medical Birth 
Register, for twins born 1973-1985, and data from original birth records store in 
medical archives for the twins born before 1973. Since it is possible that for certain 
twin pairs the birth record for a twin has been incorrectly associated with the personal 
identification number of his/her co-twin, we used two algorithms to determine whether 
this cross-over occurred or not. The algorithm for twins born 1959-1972 used birth 
weight, time of birth and name if this was given at birth. Instead the second algorithm, 
used for twins born 1973-1985, was based on the one developed by Johansson and 
Rasmussen and used information on birth weight, birth order and who was the heavier 
twin at birth.117 Both algorithms used information from medical records and the 
STAGE survey.  
 
 
4.4 STATISTICAL METHODS 
4.4.1 Generalized estimating equations  
Since women enrolled in STAGE are twins, it is possible that urinary incontinence is 
positively correlated within twin pairs. Therefore, when we evaluate the association 
between urinary incontinence and potential risk factors using twin data, the correlation 
within twin pairs must be taken into account. For this reason, a logistic regression 
model based on generalized estimating equations (GEE) has been used.118 If we had 
analyzed our data with a simple logistic regression, rather than a GEE model, we would 
have introduced substantial bias in the estimates of regression coefficients variances, 
leading to an incorrect inference of the regression coefficients.119 One of the advantages 
of using generalized estimating equations is that when the aim of the study is to 
evaluate the relationship between the population-averaged mean response and a set of 
covariates, the GEE method provides consistent inference under the assumption that the 
model for the mean is correctly specified. If the specification of the variance matrix is 
incorrect, there may be a loss in efficiency but consistency is retained.120 The 
GENMOD procedure in SAS software (version 9.2 and 9.3; SAS Institute, Cary, NC, 
USA) has been utilized to analyze the data. 
 
 
4.4.2 Co-twin control analysis 
When twin data is analyzed and an association between a disease and a potential risk 
factor is established, it is possible to determine whether the association is confounded 
or not by familial factors, such as common genes or shared environmental factors, 
using a method called co-twin control analysis.121 In the co-twin control analysis, only 
discordant twin pairs are analyzed: this means that only twin pairs where one twin is 
affected by a specific urinary incontinence subtypes while the other twin is not affected 
by that particular type of incontinence are included in the analysis.   
 
This method resembles a matched case-control design, in which twins are matched for 
several factors: intrauterine exposures, maternal factors, 50% (for dizygotic twins) or 
100% (for monozygotic twins) of their segregating genes, and childhood and 
adolescent environment. To analyze the discordant twin pairs, a conditional logistic 
regression model has been used: only twin pairs that are discordant for both the 
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outcome and the exposure of interest contribute to the likelihood of the conditional 
logistic regression model.  
 
The conditional logistic regression model is stratified by zygosity. If there is no 
difference between results obtained from the co-twin control analysis, based on 
discordant twin pairs only, and the ones observed in the GEE model, where all twins 
were included in the analysis, then it is likely that familial factors do not confound the 
association of interest. However, if an attenuation of the association is observed in the 
co-twin control analysis then the association may be confounded by familial factors. 
Particularly, an attenuation of the association only among monozygotic (MZ) twins, 
and not among dizygotic (DZ) twins, suggests that the association could be confounded 
by genetic factors. An attenuation of the association in both MZ and DZ twins suggests 
that shared environmental factors may confound the association of interest.  
 
 
4.4.3 Quantitative genetic analysis 
One of the purposes of quantitative genetic analysis is to estimate the proportion of 
phenotypic variance (in case of univariate analysis) or covariance (in case of 
multivariate analysis) that is explained by genetic or environmental factors. This can be 
accomplished by comparing the similarity of monozygotic and dizygotic twin pairs.122 
A quantitative genetic analysis was performed in Study III in order to quantify the 
contribution of genetic factors to the correlation between depressive mood disorders 
(depressive symptoms and major depression), neuroticism, and urinary incontinence.  
 
Univariate analysis  
In univariate analysis, the variance of a phenotype (P) may be partitioned into different 
variance components: additive genetic effects (A), dominance genetic effects (D), 
shared environmental effects (C), and unique environmental components (E): 
 
Var(P) = Var(A) + Var(D) + Var(C) + Var(E) 
 
By standardizing the previous formula, i.e. dividing by Var(P), we obtain: 
   
1 = a2 + d2 + c2 + e2, 
 
where a2 = Var(A)/Var(P); d2 = Var(D)/Var(P); c2 =Var(C)/Var(P); e2 = Var(E)/Var(P). 
 
This model relies on a series of basic assumptions: 
- MZ twins share all additive and non-additive genetic variance 
- DZ twins share half of the additive genetic and one-fourth of the dominance 
genetic effects 
- MZ and DZ twins share all their shared environmental effects and none of the 
unique environmental effects 
- all the variance components are uncorrelated 
- no gene-environment interaction 
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Based on these assumptions we can specify the MZ and DZ correlation as: 
 
Cor(MZ) = a2 + d2 + c2 
Cor(DZ) = 0.5a2 + 0.25d2 + c2 
 
The proportion of the phenotypic variance that is explained by genetic factors is called 
heritability (h2). There are two different definitions of heritability: the narrow-sense 
heritability is the proportion of the phenotypic variance explained by additive genetic 
effects only, while the broad-sense heritability is the proportion of variation due to both 
additive and dominance genetic factors.123 
 
One of the problems of using only twin pairs in a quantitative genetic analysis is that 
the model is underspecified. In fact, there are four unknown parameters (a2, d2, c2, e2) to 
predict three distinct statistics (Var(P),Cor(MZ),Cor(DZ)). For this reason we need to 
assume that one of the parameters is zero in order to estimate the three remaining. In a 
study of twins reared together, dominant and shared environmental effects are 
negatively confounded; for this reason it is not possible to estimate both these 
components in the same model.122 In study III we therefore decided to ignore 
dominance genetic effect (D). The consequence of setting the dominant genetic 
component (D) to zero may inflate the additive genetic component (A).  
 
Liability-threshold model 
Quantitative genetic theory assumes that the phenotype of interest is a continuous and 
normally distributed variable. However, many phenotypes are not continuous but are 
rather binary or categorical. When the phenotype is binary, or categorical, the 
quantitative genetic model can be extended through the liability threshold model.124 In 
the liability threshold model, every individual has a liability to develop a certain 
phenotype but only those with a liability score above a certain threshold actually 
develop this phenotype. These liability scores are unobservable but the liability 
threshold model assumes that their distribution is normally distributed.  
 
Multivariate analysis 
While in a univariate quantitative genetic analysis the aim is to partition the phenotypic 
variance, in a multivariate analysis the aim is to decompose the covariance between two 
phenotypes into a genetic and environmental component. In a trivariate setting, as in 
Study III, the covariance matrix is a 3x3 matrix where on the diagonal are present the 
variances of the two traits, while the off diagonal element represents the covariance 
between these two traits. This covariance matrix (Cp) can be decomposed as:  
 
Cp = A + C + E 
 
The matrices A, C and E respectively represent the additive genetic, shared 
environmental, and unique environmental covariance matrix. To estimate the elements 
of these matrices, the maximum likelihood method implemented in the structural 
equation modeling package Mx can be used.125 126 At first a model where all these three 
sources of covariation were present is fitted and then subsequent models can be tested 
to examine the worsening of the model fit caused by the removal of the various sources 
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of variation. The goodness of fit of the reduced models can be evaluated using the 
likelihood ratio test and the Akaike´s Information Criteria (AIC).  In Study III, where 
we performed a trivariate analysis using neuroticism, major depression (or depressive 
symptoms), and urinary incontinence, we have found that the best-fit model was the AE 
model. Therefore we can simplify the previous formula as: 
 
Cp = A + E 
 
The matrices A and E can explicitly be written as: 
 
 
𝐴 = �𝑎11 𝑎12 𝑎13𝑎21 𝑎22 𝑎23
𝑎31 𝑎32 𝑎33
�                𝐸 = �𝑒11 𝑒12 𝑒13𝑒21 𝑒22 𝑒23
𝑒31 𝑒32 𝑒33
� 
 
 
If A is diagonal, then this means that the three phenotypes are genetically independent. 
If A instead has a significant off diagonal element, then genetic influences might have 
an effect on the phenotypes: for example if the element a32 is significant, then there are 
genetic factors in common between the second and the third phenotype (depressive 
mood disorders and incontinence). 
 
In order to estimate the matrices A and E, we have to impose that they are positive 
definite since they are covariance matrices. A symmetric n x n matrix M is said to be 
positive definite if z´Mz (where z´ is the transpose of z) is positive for any non-zero 
column vector z of n real numbers. If we do not impose this constraint, the estimated 
matrices might not be positive definite and therefore will provide incorrect values for 
the genetic and environmental correlation (for example above the unity). Any positive 
definite matrix (B) can be decomposed in the product of a triangular matrix (T, a matrix 
having zeros in all elements above the main diagonal) and its transpose (T´): 
 
𝐵 = 𝑇𝑇´ 
 
This decomposition is called Cholesky decomposition or Cholesky triangle. Therefore, 
to make sure that the matrices A and E are positive definite we can represent these 
matrices by using their Cholesky decomposition: 
 
𝐴 = 𝑋𝑋´                   𝐸 = 𝑍𝑍´  
 
Genetic and environmental correlations 
Once we have obtained the genetic and unique environmental matrices (A and E), we 
can estimate the extent to which genetic influences in one trait overlap with those of the 
other trait. This information is provided by the genetic correlation (rg) estimated with 
the following formula: 
 
𝑟𝑔 = 𝑎32
�𝑎22 × 𝑎33 
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The genetic correlation indicates the extent to which genetic influences in one trait (the 
3rd trait in this example) overlap with those of another trait (the 2nd trait). 
 
Using a similar formula, we can also estimate the unique environmental correlation 
(re): 
 
𝑟𝑒 = 𝑒32
�𝑒22 × 𝑒33 
 
The observed phenotypic correlation (rp) can be defined as a function of the genetic and 
environmental correlation as: 
 
𝑟𝑝 = 𝑟𝑔ℎ𝑥ℎ𝑦 +  𝑟𝑒𝑒𝑥𝑒𝑦 
 
where hx and hy are the square roots of the estimated heritability for, respectively, the 
second and the third phenotype, and ex and ey are the square roots of the proportion of 
the variation of these two traits that is explained by non-shared environmental factors. 
The proportion of the phenotypic correlation explained by shared genetic factors can be 
estimated as: 
 
𝑟𝑔ℎ𝑥ℎ𝑦/𝑟𝑝 
 
This quantity is a measure of the extent to which shared genetic influence generates a 
correlation between two traits. If we found that this quantity is equal to 0.8, it means 
that 80% of the total phenotypic correlation is explained by shared genetic influences. 
However, the proportion of the correlation explained by shared genetic factors is 
distinct from the genetic correlation. Even if two traits have a very high genetic 
correlation, if neither trait is strongly heritable then shared genetic factors are unlikely 
to explain much of the observed correlation between the two traits. 
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5 RESULTS 
 
5.1 CHARACTERISTICS OF WOMEN ENROLLED IN STAGE 
More than fourteen thousand female twins were enrolled in STAGE (n = 14,094). The 
prevalence and frequency of women affected by different lower urinary tract symptoms 
is reported in Table 5.  
 
Table 5. Prevalence of urinary incontinence (UI) and other urological conditions 
among women enrolled in STAGE 
Lower urinary tract 
symptoms (LUTS) 
Number of women 
affected by LUTS 
Prevalence (%) 
Overall UI 929 6.59 
Stress UI 769 5.46 
Urge UI 401 2.84 
Mixed UI 312 2.21 
Overactive bladder  1,185a    1,307b 8.41a    9.27b 
Nocturia 3,138 22.3 
a Definition used in Study I 
b Definition used in Study II 
 
Among women in STAGE, stress urinary incontinence is the most common urinary 
incontinence subtype, followed by urge incontinence and then by mixed urinary 
incontinence. Almost a quarter of the women (22.3%) reported that they usually wake 
up at least two times per night to urinate. While nocturia was the outcome of interest 
only in Study I, overactive bladder was analyzed in both Study I and Study II but the 
prevalence of overactive bladder was different in the two studies. The reason for this 
difference was that in Study I women were defined as affected by overactive bladder 
using only the question “Do you experience sudden urgency to void with little or no 
warning?”, while in Study II also women affected by urge urinary incontinence were 
defined as having overactive bladder since urge incontinence is one of the main 
symptoms that characterizes individuals with overactive bladder.   
 
The age distribution for all the female twins participating in STAGE and for women 
affected by lower urinary tract symptoms is shown in Figure 4. The age distribution of 
all the women enrolled in STAGE is quite constant except for 20 years old women: the 
number of women of this age is almost halved compared to the other ages since the 
invitation letter was sent out only to women who were already 20 years old before May 
2005. For all urinary incontinence subtypes, the age distribution increases with age 
while for nocturia and overactive bladder the distribution is more constant.  
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Figure 4. Age distribution of women enrolled in STAGE 
 
 
Table 6 reports the prevalence of lower urinary tract symptoms according to body mass 
index (categorized following World Health Organization guidelines [<18.5 = 
underweight, 18.5-24.9 = normal weight, 25-29.9 = overweight, >30 obese]). The 
prevalence of all lower urinary tract symptoms increases with body mass index: obese 
women have a particularly higher risk of LUTS. In this subgroup of women, the 
prevalence of incontinence is almost tripled compared to women with a normal weight, 
while the prevalence of overactive bladder is doubled. 
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Table 6. Prevalence of lower urinary tract symptoms according to body mass index 
Body mass 
index 
N Overall 
UIa 
Stress 
UIa 
Urge 
UIa 
Mixed 
UIa 
Nocturiaa Overactive 
bladdera 
Underweight 496 3.2 2.4 1.4 0.6 23.6 12.7 
Normal 
weight 
9,411 6.1 4.9 2.5 1.8 23.5 11.2 
Overweight 2,213 8.5 7.3 3.7 3.1 30.0 14.8 
Obese 733 17.4 15.1 8.8 7.4 35.9 22.2 
a Values represent the prevalence of each LUTS 
 
Also for nocturia the prevalence increases with body mass index, however the 
difference between obese and women with a normal body weight is less pronounced. 
 
Another important risk factor for urinary incontinence is parity. For all urinary 
incontinence subtypes there is a substantial difference in the prevalence between 
nulliparous women and women who have given birth only once. Moreover, the 
prevalence of urinary incontinence increases with the number of deliveries. For 
nocturia and overactive bladder there is a pronounced difference between nulliparous 
women and women with only one child, but the prevalence does not increase with 
increasing parity (Table 7). 
 
Table 7. Prevalence of lower urinary tract symptoms according to parity 
Number of 
children 
N Overall 
UIa 
Stress 
UIa 
Urge 
UIa 
Mixed 
UIa 
Nocturiaa Overactive 
bladdera 
0 5,719 2.5 1.5 1.3 0.7 21.2 11.1 
1 1,901 8.8 7.8 3.7 3.3 35.9 15.7 
2 3,678 10.6 8.9 4.2 3.5 25.9 12.2 
More than 2 1,854 12.4 11.0 5.2 4.4 26.2 13.6 
a Values represent the prevalence of each LUTS 
 
 
5.2 STUDY I 
The aim of Study I was to evaluate the association between coffee and tea consumption 
and urinary incontinence and to determine whether the effect of coffee and tea on 
incontinence was confounded by familial factors, such as common genes or 
environmental factors shared during childhood and young adulthood. 
 
Among women who participated at the STAGE survey, seventy-two percent reported 
that they usually drank at least one cup of coffee per day while almost forty-seven 
percent drank at least one cup of tea (Table 8).   
 
In crude analysis we found that tea consumption was not associated with overall and 
urge urinary incontinence. A negative association was observed in crude analysis 
between high tea intake and mixed urinary incontinence that however became not 
significant after adjusting the analysis for other covariates (age, body mass index, 
parity, educational level, and smoking). In adjusted analysis a negative association was 
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found between high tea intake and stress urinary incontinence (OR 0.72, 95% CI 0.53-
0.99). 
 
Table 8. Coffee and tea consumption for women enrolled in STAGE 
Number of cups/day Coffee Tea 
0 cups 3917 (27.7%) 7459 (52.9%) 
1-2 cups 4392 (31.2%) 5425 (38.5%) 
3 or more cups 5722 (40.6%) 1146 (8.1%) 
Missing 63 (0.5%) 64 (0.5%) 
Values are number of women (%). 
 
A positive association was found between high tea consumption (three or more cups 
per day) and overactive bladder: the association remained statistically significant even 
after adjusting for possible confounding variables. Women who drank three or more 
cups of tea per day had a 34% higher odds of overactive bladder compared to non-tea 
drinkers (OR 1.34, 95% CI 1.07-1.67). Moreover, a small effect of tea intake on 
nocturia was found: in adjusted analysis, women who had a high tea consumption had a 
18% higher odds of nocturia compared to non-tea drinkers (OR 1.18, 95% CI 1.01-
1.38). With regard to coffee consumption, a high coffee intake was positively 
associated with all urinary incontinence subtypes (overall, stress, urge, and mixed 
urinary incontinence) but not with nocturia and overactive bladder. However, in age-
adjusted analysis the positive effect of high coffee consumption on incontinence 
disappeared: the reason for this finding is shown in Table 9 and Table 10. 
 
Table 9. Coffee consumption and age distribution of women in STAGE 
 Coffee consumption 
Age 0 cups 1-2 cups 3+ cups 
19-26 1 165 (48.6) 1 132 (33.0) 631 (18.4) 
27-33 1 114 (32.4) 1 191 (34.7) 1 130 (32.9) 
34-40 759 (19.8) 1 186 (30.9) 1 892 (49.3) 
41-47 382 (11.4) 883 (26.5) 2 070 (62.1) 
Values are number of women (%). 
 
Table 10. Age distribution and occurrence of urinary incontinence of women in 
STAGE 
 Overall urinary incontinence 
Age Yes No 
19-26 3 112 (98.0) 63 (2.0) 
27-33 3 040 (94.7) 169 (5.3) 
34-40 3 300 (91.5) 308 (8.5) 
41-47 2 762 (87.7) 389 (12.3) 
Values are number of women (%). 
 
Table 9 shows that older women had a higher coffee consumption compared to younger 
women: while approximately 18% of the women aged 19-26 had a high coffee 
consumption, among older women (age 41-47) the prevalence of women with a high 
coffee intake is tripled (62.1%). Moreover among older women, the occurrence of 
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urinary incontinence is much higher (Table 10). Therefore, in crude analysis we found 
a positive association between coffee and incontinence only because this association 
was completely determined by age. However, results from age-adjusted logistic 
regression models showed that there was no association between coffee and urinary 
incontinence. After adjusting the analysis for other potential confounders (body mass 
index, parity, smoking, and educational level) a negative association was found 
between high coffee intake and overall incontinence (OR 0.79, 95% CI 0.64-0.98). 
 
The associations that were statistically significant in the logistic regression model 
(coffee and overall urinary incontinence, tea and stress urinary incontinence, tea and 
nocturia, tea and overactive bladder) were included in a co-twin control analysis (Table 
11). Regarding the association between high coffee intake and overall urinary 
incontinence, a statistically significant association was still observed among DZ pairs 
(OR 0.41, 95% CI 0.18-0.94) but not among MZ pairs (OR 0.77, 95% CI 0.33-1.78): 
this finding suggests that the association between high coffee consumption and overall 
urinary incontinence may be confounded by shared genetic factors. Instead the effect of 
high tea intake on stress urinary incontinence, nocturia, and overactive bladder was no 
more significant in both MZ and DZ twins, suggesting that shared environmental 
factors may have confounded these associations   
 
Table 11. Co-twin control analyses of coffee and tea consumption on discordant twin 
pairs 
 MZ twins DZ twins 
Overall UI   
0 cups of coffee per day 1.0 (ref) 1.0 (ref) 
3+ cups of coffee per day 0.77 (0.33-1.78) 0.41 (0.18-0.94) 
Stress UI   
0 cups of tea per day 1.0 (ref) 1.0 (ref) 
3+ cups of tea per day 0.57 (0.14-2.28) 0.69 (0.19-2.42) 
Nocturia   
0 cups of tea per day 1.0 (ref) 1.0 (ref) 
3+ cups of tea per day 1.24 (0.68-2.27) 0.82 (0.45-1.52) 
Overactive bladder   
0 cups of tea per day 1.0 (ref) 1.0 (ref) 
3+ cups of tea per day 0.80 (0.38-1.66) 0.65 (0.27-1.57) 
Analyses adjusted for body mass index, parity, smoking, and educational level 
 
 
5.3 STUDY II 
The aim of Study II was to evaluate the effect of gestational diabetes mellitus on 
overactive bladder among parous women. For this reason the study was limited only to 
female twins who gave birth in 2005 or before (n = 7 855). Among women enrolled in 
STAGE who had given birth before 2005, 200 of them (2.5%) reported that they had a 
diagnosis of gestational diabetes mellitus in the past. Using the Medical Birth Register 
women who did not self-report GDM in the survey but have a diagnosis in the registers 
were identified using the following International Classification of Disease (ICD) codes: 
648A and 648W (ICD-9), and O24.4–O24.5 (ICD-10). Twenty-five additional women 
   29 
with a diagnosis of GDM were identified: therefore, a total of 225 women (2.9%) in 
STAGE had a history of gestational diabetes mellitus.  
 
Table 12 shows the crude association between gestational diabetes mellitus and 
overactive bladder. Approximately 2.6% of the women without overactive bladder had 
a history of gestational diabetes mellitus while among women who reported overactive 
bladder symptoms, the prevalence of GDM is almost two times higher (5.0%). Results 
from a crude logistic regression model showed that women with a history of gestational 
diabetes mellitus had a two times higher odds of overactive bladder compared to 
women without GDM (OR 2.13, 95% CI 1.49-3.05). After adjusting the logistic 
regression model for a set of potential confounders, the association remained almost 
identical to the one observed in the crude logistic regression model (OR 2.13, 95% CI 
1.48-3.05). 
 
Table 12. Gestational diabetes mellitus and overactive bladder among women enrolled 
in STAGE who gave birth before 2005 
Gestational 
diabetes mellitus 
Women without 
overactive bladder 
n = 6992 
Women with 
overactive bladder 
n = 863 
Crude OR 
(95% CI) 
Yes 182 (2.6) 43 (5.0) 2.13 (1.49–3.05) 
No 6125 (87.6) 734 (85.0) 1.0 (reference) 
Missing 685 (9.8) 86 (10.0) - 
 
The logistic regression model has been further adjusted for a potential mediator, 
diabetes mellitus. Gestational diabetes mellitus is considered a risk factor for type 2 
diabetes mellitus later in life and at the same time diabetes mellitus has been suggested 
as a potential risk factor for overactive bladder. Table 13 shows that women with 
diabetes mellitus had a higher prevalence of overactive bladder (17.5% vs. 11.1%). 
Moreover, more than 37% of the women with a history of gestational diabetes mellitus 
developed diabetes mellitus, while only 0.5% of the women without GDM had 
diabetes. 
 
Table 13. Gestational diabetes mellitus, diabetes mellitus and overactive bladder 
 Overactive bladder 
Diabetes mellitus Yes No 
Yes 22 (17.5) 104 (82.5) 
No 840 (11.1) 6752 (88.9) 
Missing 1 (0.7) 136 (99.3) 
 
 Diabetes mellitus 
Gestational diabetes mellitus Yes No 
Yes 84 (37.3) 141 (62.7) 
No 38 (0.5) 6821 (99.5) 
Missing 4 (0.1) 636 (99.9) 
 
After adjusting for diabetes mellitus, the association between gestational diabetes 
mellitus was attenuated but still statistically significant. Women with a history of GDM 
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had a 88% higher odds of overactive bladder (OR 1.88, 95% CI 1.26-2.80). While in 
the first two models diabetes mellitus was positively associated with overactive 
bladder, after adjusting for GDM the association between diabetes mellitus and 
overactive bladder was no more statistically significant indicating that the association 
observed in the previous models was confounded by GDM (Table 14).  
 
Table 14. Odds ratios for overactive bladder in relation to gestational diabetes mellitus 
and diabetes mellitus in multivariable logistic regression analysis 
 Adjusted ORa Adjusted ORb Adjusted ORc 
No GDM or DM 1.0 (reference) 1.0 (reference) 1.0 (reference) 
GDM 2.11 (1.47–3.03) 2.13 (1.48–3.05) 1.88 (1.26–2.80) 
Diabetes mellitus 2.03 (1.23–3.34) 2.02 (1.23–3.33) 1.42 (0.83–2.43) 
a Adjusted for age, body mass index, and parity. 
b Adjusted for age, body mass index, parity, smoking, and educational level. 
c Adjusted for age, body mass index, parity, smoking, and educational level. Gestational diabetes mellitus 
(GDM) and diabetes mellitus (DM) are included in the same model.  
 
Two interaction terms between diabetes mellitus and GDM and body mass index and 
GDM were included in the logistic regression model to evaluate whether the effect of 
GDM differed among women with and without diabetes and among women with low 
and high body mass index. However, we found that both interaction terms were not 
statistically significant (p = 0.09 for diabetes mellitus and p = 0.58 for body mass 
index).  
 
We also evaluated whether women with a recent diagnosis of GDM (time since 
diagnosis ≤ 5 years) had a higher odds of overactive bladder compared to women who 
had a diagnosis of GDM more than 5 years before the survey. Results are shown in 
Table 15. 
 
Table 15. Effect of time since GDM diagnosis on overactive bladder 
 Adjusted OR 
No GDM 1.0 (reference) 
GDM diagnosis ≤ 5 years 2.20 (0.83-5.83) 
GDM diagnosis > 5 years 1.78 (1.10-2.87) 
Analysis adjusted for age, body mass index, parity, smoking, educational level, and diabetes mellitus 
 
Women who had gestational diabetes mellitus less than five years before the survey, 
had a two times higher odds of overactive bladder. This finding was not statistically 
significant (OR 2.20, 95% CI 0.83-5.83), probably because only 42 women had a 
diagnosis of GDM five years before the survey of which only seven had overactive 
bladder. Moreover, no difference between women who had recent diagnosis and 
women who had gestational diabetes mellitus more than five years ago was observed  
(p = 0.69). For 31 women with a diagnosis of gestational diabetes mellitus, no 
information regarding the time of diagnosis was available. 
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5.4 STUDY III 
The aims of Study III were to evaluate the association between depressive mood 
disorders (major depression and depressive symptoms) and neuroticism with urinary 
incontinence and to determine the contribution of genetic factors to these associations. 
 
Among the women enrolled in STAGE, 23.8% had current depressive symptoms 
(defined as a CES-D score equal to or greater than eight), 25.9% scored high on the 
neuroticism scale (i.e. had a score of five or greater), and 7.9% had major depression. 
UI subtypes were more common among women affected by depression (Table 16). 
Moreover, mean CES-D and neuroticism scores were higher among women with 
urinary incontinence. 
 
Table 16. CES-D and neuroticism age-adjusted mean scores and prevalence of urinary 
incontinence among women with and without major depression  
 All women 
N = 14 094 
Overall UI 
N = 929 
Stress UI 
N = 769 
Urge UI 
N = 401 
Mixed UI 
N = 312 
CES-D      
Mean scorea 
(SD) 
5.71 (0.05) 7.55 (0.27) 7.33 (0.25) 8.45 (0.41) 8.16 (0.40) 
Missing (%) 1 963 (13.9) 89 (9.5) 75 (9.7) 37 (9.2) 32 (10.2) 
Neuroticism      
Mean scorea 
(SD) 
3.08 (0.02) 3.94 (0.12) 4.02 (0.12) 4.37 (0.16) 4.40 (0.16) 
Missing (%) 3 115 (22.0) 212 (22.8) 173 (22.4) 86 (21.4) 66 (21.1) 
Major 
depressionb 
     
    Yes  870 103 (11.8) 84 (9.7) 49 (5.6) 36 (4.1) 
    No 10 113 614 (6.1) 512 (5.1) 266 (2.6) 210 (2.1) 
    Missing 3 111 212 (6.8) 173 (5.5) 86 (2.8) 66 (2.1) 
a Age-adjusted means  
b Values are number of women with UI (% of women with UI). 
 
In adjusted logistic regression analysis, depressive symptoms, depression, and 
neuroticism were positively associated with all urinary incontinence subtypes (Table 
17). However, when all these three variables were included in the same logistic 
regression model, all associations were attenuated. The association between depression 
and overall and stress UI was almost halved (OR = 1.45, 95% CI 1.11-1.91 for overall 
urinary incontinence; OR = 1.38, 95% CI 1.03-1.86 for stress urinary incontinence), 
while the effect of major depression on urge, as well as mixed, incontinence was no 
longer statistically significant (OR = 1.20, 95% CI 0.83-1.73 for urge incontinence; OR 
= 1.05, 95% CI 0.68-1.61 for mixed incontinence).  
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Table 17. Associations between major depression, depressive symptoms, and 
neuroticism with urinary incontinence 
 Adjusted ORa Multi-adjusted ORb 
Overall UI   
Depression 1.99 (1.55-2.55) 1.45 (1.11-1.91) 
CES-D 1.38 (1.27-1.50) 1.22 (1.10-1.36) 
Neuroticism 1.38 (1.27-1.51) 1.23 (1.10-1.38) 
Stress UI   
Depression 1.89 (1.44-2.48) 1.38 (1.03-1.86) 
CES-D 1.36 (1.25-1.49) 1.20 (1.07-1.34) 
Neuroticism 1.39 (1.26-1.52) 1.24 (1.10-1.40) 
Urge UI   
Depression 1.92 (1.35-2.73) 1.20 (0.83-1.73) 
CES-D 1.58 (1.39-1.80) 1.31 (1.11-1.55) 
Neuroticism 1.72 (1.49-1.98) 1.55 (1.29-1.86) 
Mixed UI   
Depression 1.68 (1.10-2.56) 1.05 (0.68-1.61) 
CES-D 1.56 (1.34-1.80) 1.29 (1.07-1.56) 
Neuroticism 1.75 (1.50-2.05) 1.61 (1.30-1.99) 
a Adjusted for age, parity, body mass index, and antidepressant medication    
b Major depression, CES-D, and neuroticism were all included in the same model 
 
The attenuation of the associations observed in the multi-adjusted logistic regression 
models was mainly determined by neuroticism. In fact, women who score high on the 
neuroticism scale were more likely to have both current depressive symptoms and 
major depression (Table 18).  
 
Table 18. Neuroticism, depressive symptoms, and major depression 
 Depressive symptoms Major depression 
 Yes No Yes No 
High neuroticism 1446 (55.0) 1185 (45.0) 463 (22.0) 1640 (78.0) 
Low neuroticism 993 (13.0) 6642 (87.0) 379 (5.2) 6917 (94.8) 
 
Since neuroticism confounded the effect of depressive symptoms and major depression 
on urinary incontinence, a trivariate Cholesky decomposition model was used to assess 
the proportion of the phenotypic correlation between depressive mood disorders 
(depressive symptoms and major depression) and urinary incontinence that was 
determined by common genetic factors. Moreover, in the trivariate Cholesky 
decomposition model with neuroticism, depressive mood disorders, and urinary 
incontinence it was possible to determine how much of the genetic factors that were 
shared between depressive mood disorders and incontinence were also in common with 
neuroticism.  
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In more detail, if we consider the trivariate model with neuroticism, major depression, 
and urinary incontinence, the best-fit model was the AE model (Figure 5).  
 
Figure 5. Trivariate Cholesky decomposition model with neuroticism, major 
depression, and overall urinary incontinence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The additive genetic and unique environmental matrices were: 
 
𝐴 = �0.47 0.25 0.070.25 0.44 0.150.07 0.15 0.62�                𝐸 = �0.53 0.19 0.080.19 0.56 0.080.08 0.08 0.38� 
 
In this particular case, the genetic correlation between major depression and overall 
urinary incontinence is given by: 
 
𝑟𝑔 = 0.15
√0.44 × 0.62 = 0.29 
 
This means that 29% of the genetic influences of major depression was in common 
with overall incontinence. 
 
Using the square roots of the estimated heritability of the two phenotypes, the 
proportion of the phenotypic correlation that is explained by common genes can be 
estimated as: 
 
𝑟𝑔ℎ𝑥ℎ𝑦
𝑟𝑝
= 0.29 × 0.66 × 0.790.23 = 0.64 
 
This finding suggests that 64% of the phenotypic correlation between major depression 
and overall incontinence was explained by common genetic factors.  
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The fact that the best-fit model contained a path from major depression to overall 
incontinence indicates that some of the genetic factors that were in common between 
depression and overall incontinence were not shared with neuroticism. Moreover, by 
multiplying the genetic correlation between neuroticism and depression with the 
genetic correlation between neuroticism and overall incontinence, and by dividing this 
product by the genetic correlation between depression and overall incontinence, it is 
possible to determine how much of the genetic correlation between depression and 
overall incontinence was shared with neuroticism. Approximately 25% of the genetic 
factors that were shared between depression and overall incontinence were also in 
common with neuroticism.  
 
Results from quantitative genetic analysis showed that there was a modest genetic 
correlation between depressive mood disorders and overall and stress incontinence. 
However, part of the variance that these traits shared due to genetic causes was also in 
common with neuroticism. In fact, approximately 25-35% of the genetic factors shared 
between depressive mood disorders and overall, or stress, urinary incontinence were in 
common with neuroticism. Also for urge and mixed incontinence a modest genetic 
correlation was observed: however, the genetic factors that were shared between 
depressive mood disorders and urge, or mixed, incontinence were completely in 
common with neuroticism since the best-fit models did not include the path from 
depressive mood disorders to urge or mixed incontinence.  
 
Moreover, the majority of the phenotypic correlation, approximately 50-70%, between 
depressive mood disorders and incontinence was determined by shared genetic factors. 
These findings suggest that the association between depressive mood disorders and 
urinary incontinence are in part determined by genetic factors in common to the 
disorders. 
 
 
5.5 STUDY IV 
The aim of Study IV was to determine the effect of birth characteristics, such as birth 
weight and being born small for gestational age, on urinary incontinence.  
 
The analysis was restricted only to female twins with known birth order (n = 11,175). 
Approximately nine percent of these twins (9.3%, n = 1039) were born small for 
gestational age while almost 43% of the twins had a low birth weight, i.e. a birth weight 
below 2,500 grams (n = 4,773). Among women born small for gestational age, the 
prevalence of urinary incontinence subtypes was very similar to the prevalence 
observed among women not SGA. Moreover, no differences in the prevalence of 
urinary incontinence across groups of women with different birth weight were 
observed.  
 
Logistic regression analyses confirmed these findings. In both crude and adjusted 
analysis being born small for gestational age had no effect on all urinary incontinence 
subtypes: odds ratios ranged from 0.97 to 1.13. No association was observed also 
between birth weight and urinary incontinence. 
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An interaction term was added to the model to evaluate the interaction between low 
birth weight (or being born SGA) and body mass index later in life. No interaction was 
observed between SGA and body mass index, while the interaction between low birth 
weight and body mass index was borderline statistically significant for overall 
incontinence (p-value = 0.06) and statistically significant for stress urinary incontinence 
(p-value = 0.04).  
 
Women who had a low birth weight and then became overweight later in life, or obese, 
had the highest prevalence of overall and stress urinary incontinence. Regarding urge 
and mixed urinary incontinence, the prevalence of these urinary incontinence subtypes 
among overweight women who had a low birth weight was almost identical to the 
prevalence among overweight women who had a normal birth weight. 
 
Results from logistic regression models showed that women who became overweight 
or obese later in life had a higher odds of incontinence (overall and stress urinary 
incontinence) compared to women who were not overweight and had a birth weight 
above 2,500 grams (Table 19). The highest odds of urinary incontinence were observed 
among overweight women who had a low birth weight (OR = 1.84, 95% CI 1.39-2.45 
for overall urinary incontinence; OR = 1.83, 95% CI 1.35-2.48 for stress urinary 
incontinence). The difference between overweight women with a low birth weight and 
overweight women who had birth weight above 2,500 grams was borderline 
statistically significant (p-value = 0.06 for overall urinary incontinence, p-value = 0.08 
for stress urinary incontinence). 
 
Table 19. Combined effect of low birth weight and body mass index later in life on 
urinary incontinence 
  Crude OR Adjusted OR1 Adjusted OR2 
Overall UI    
Not LBW and not                            
overweight 
1.0 (reference) 1.0 (reference) 1.0 (reference) 
  LBW and not 
overweight 
0.92 (0.77-1.11) 0.96 (0.77-1.20) 0.95 (0.75-1.21) 
  Not LBW and 
overweight 
1.58 (1.28-1.94) 1.56 (1.25-1.95) 1.36 (1.08-1.73) 
  LBW and overweight 1.84 (1.46-2.31) 2.05 (1.58-2.67) 1.84 (1.39-2.45) 
Stress UI    
Not LBW and not 
overweight 
1.0 (reference) 1.0 (reference) 1.0 (reference) 
  LBW and not 
overweight 
0.88 (0.72-1.08) 0.89 (0.69-1.14) 0.90 (0.69-1.17) 
  Not LBW and 
overweight 
1.59 (1.26-1.99) 1.57 (1.23-2.00) 1.35 (1.05-1.75) 
  LBW and overweight 1.93 (1.51-2.47) 2.10 (1.58-2.79) 1.83 (1.35-2.48) 
1 Adjusted for gestational age and maternal age 
2 Adjusted for gestational age, maternal age, maternal parity, socioeconomic status, and birth cohort 
LBW denotes low birth weight (<2,500 grams) 
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6 DISCUSSION 
 
6.1 MAIN FINDINGS  
 
Coffee and tea consumption and urinary incontinence 
 
Study I showed that high tea consumption was associated with increased odds of 
overactive bladder and nocturia, as well as significantly lower odds of stress urinary 
incontinence. Moreover, women with a high coffee intake had lower odds of overall 
urinary incontinence. However, results from co-twin control analysis suggested that the 
associations were confounded by shared genetic and environmental factors.  
 
Previous studies reported that coffee drinking was associated with an increased risk of 
urinary incontinence.52-54 A study has shown that women with overactive bladder after 
drinking caffeine had a statistically significant increase in detrusor pressure during the 
bladder filling phase.52 Given that caffeine beverages may exacerbate urinary 
incontinence, the 4th International Consultation on Incontinence recommended 
reduction of caffeine intake for women affected by incontinence symptoms.127  
 
Our findings of no effect of coffee consumption on urinary incontinence are in 
agreement with results from Hannestad et al.,44 in which no association was found 
between coffee drinking and incontinence in an age-adjusted cross-sectional analysis of 
Norwegian women aged 20–90 years. Moreover, a longitudinal study conducted in 
women aged 40 years or older found no effect of coffee and tea on overactive bladder 
and stress incontinence.56 
 
A recent cross-sectional study performed among 4,309 nonpregnant US women, 
reported that women with a high caffeine intake (>200 mg/day) had a 47% higher odds 
of overall urinary incontinence compared to women with no caffeine intake.128 
However, no association was found between high caffeine intake and moderate/severe 
urinary incontinence. The different findings between the US study and ours can be 
explained by several differences. First of all, in our study we looked only at the effect 
of coffee and tea consumption on incontinence while in the US study other sources of 
caffeine were considered (i.e. soft drinks and chocolate). Moreover, in the US study a 
yearly definition of incontinence was utilized, while in our study women were defined 
as affected by incontinence if they had an involuntary loss of urine in the last month. 
Lastly, women enrolled in our study were mostly Caucasians while women of more 
divergent race/ethnicity participated in the US study. 
 
A limitation of this study was the limited number of discordant twin pairs. In fact, it is 
possible that in the co-twin control analysis the associations were non-significant 
because of an insufficient number of discordant twin pairs rather than familial 
confounding. Another limitation of this study is that, since it was a cross-sectional 
study, information regarding disease and exposures were collected at the same time and 
it was not possible to determine whether the exposure preceded the disease or vice 
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versa. In fact, women with urinary incontinence may have decided to restrict their fluid 
intake, including coffee and tea, to improve their urinary symptoms.  
 
Gestational diabetes mellitus and overactive bladder 
 
In Study II we found that a history of gestational diabetes mellitus was positively 
associated with overactive bladder. Moreover, the association remained statistically 
significant even after adjusting for body mass index and diabetes mellitus, indicating 
that the effect of gestational diabetes mellitus on overactive bladder was not mediated 
by body mass index or diabetes later in life.  
 
Few studies have evaluated the effect of gestational diabetes mellitus on urinary 
symptoms. A cross-sectional study of 228 women with a history of GDM reported that 
stress urinary incontinence was common among these women.66 However, since there 
was no comparison group (i.e. a group of women without GDM) the authors were not 
able to evaluate the effect of gestational diabetes mellitus on stress incontinence. A 
recent prospective study performed among Taiwanese women reported that gestational 
diabetes mellitus was a risk factor for stress, urge, and mixed incontinence: women 
with GDM had an approximately two times higher odds of incontinence.67 However, 
authors did not adjust for postpartum diabetes mellitus or postpartum body weight.  
 
Even though it is not possible to determine the underlying mechanisms behind 
gestational diabetes mellitus and overactive bladder in our study, the positive 
association between OAB and GDM could be a result of subclinical cystopathy in the 
aftermath of pregnancy. This process may share pathoetiological mechanisms with 
diabetes mellitus, such as neurogenic, myogenic, and microvascular bladder sequela of 
chronic hyperglycaemia in individuals who may not have developed diabetes. 
Moreover, previous studies have reported that diabetes mellitus,59-63 gestational 
diabetes mellitus,67 and the metabolic syndrome129 are positively associated with UI, 
suggesting that metabolic effects of pregnancy may explain some of the urinary 
symptoms observed after the delivery. 
 
Due to the cross-sectional design of this study, it was not possible to determine whether 
women had overactive bladder symptoms before the diagnosis of gestational diabetes 
mellitus. However, it seems unlikely that overactive bladder syndrome preceded 
gestational diabetes given the young age at pregnancy of the study population. Another 
limitation of the present study was that there were insufficient numbers of discordant 
twin pairs to perform a co-twin control analysis: therefore it was not possible to 
determine whether the association was confounded by familial factors. Moreover, given 
the low number of women affected by gestational diabetes mellitus in STAGE, we 
were not able to evaluate how GDM severity affected overactive bladder. 
 
In this study we found that women with a history of gestational diabetes mellitus had an 
almost two times higher odds of overactive bladder but only 3% of the women had 
GDM: therefore, very few women had overactive bladder because of GDM in our 
study. However, the prevalence of gestational diabetes mellitus is lower in Northern 
Europe (approximately 2-3%) compared to the South (~6%)70: since the prevalence of 
GDM is higher in Southern Europe, more women could be affected by overactive 
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bladder because of gestational diabetes mellitus in these countries. Moreover, the 
prevalence of gestational diabetes mellitus has increased by ~ 10/100% in several 
race/ethnicity groups in the last 20 years.130 The trend toward older maternal age, the 
epidemic of diabetes and obesity, and the decrease in physical activity could increase 
the prevalence of gestational diabetes mellitus even further, causing more women to be 
affected by overactive bladder symptoms because of GDM.130  
 
Neuroticism, depressive mood disorders and urinary incontinence 
 
Several studies have evaluated the association between depressive mood disorders and 
incontinence.72-75 Moreover, the importance of genetic factors for liability of urinary 
incontinence,5-8 major depression,131 and neuroticism132 133 has been shown in previous 
studies. However, this is the first study that has assessed the contribution of familial 
factors to the co-morbidity of incontinence with depressive mood disorders and 
neuroticism. 
 
Our study confirmed that neuroticism and depressive mood disorders are positively 
associated with incontinence. However, in the multi-adjusted model we found that the 
effect of major depression on urge and mixed incontinence was confounded by 
neuroticism. Moreover, in quantitative genetic analysis we found a modest genetic 
correlation between depressive mood disorders and incontinence. Another important 
finding of this study was that for overall and stress incontinence the genetic factors that 
were shared with depressive mood disorders were only partially shared with 
neuroticism, while for urge and mixed incontinence the genetic overlap with depressive 
mood disorders was completely in common with neuroticism. These findings suggest 
that genetic variants for neuroticism are driving the association between depressive 
mood disorders and incontinence.  
 
Different theories have been proposed to explain the association between depressive 
mood disorders and incontinence. One possible explanations is that a decreased 
serotonin activity can lead to depression134 and also have an effect on bladder 
function.74 A different theory suggests that the increased activity of the hypothalamic-
pituitary axis seen in depressed individuals may determine physiological changes in the 
bladder, causing incontinence. 
 
One of the limitations of this study was that due to the low number of twin pairs that 
were discordant for both urinary incontinence and depressive mood disorders (or 
neuroticism), confidence intervals in the co-twin control analysis were wide: therefore 
it was difficult to determine if the associations were not significant because of familial 
confounding or simply because of low statistical power. 
 
Since this is the first study that has evaluated the genetic contribution to the association 
between depressive mood disorders, neuroticism, and incontinence, it was not possible 
to compare our findings with previous studies. However, the heritability estimates for 
urinary incontinence, depression, and neuroticism that we reported in our study were 
similar to the estimates reported in previous studies.5 131 132 
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Birth characteristics and urinary incontinence  
 
In Study IV we found that birth weight and being born small for gestational age had no 
effect on urinary incontinence. However, when we included in the model an interaction 
term between low birth weight and body mass index later in life we found that women 
who had a low birth weight and then became overweight had a borderline statistically 
significant higher odds of incontinence compared to overweight women who had a 
normal birth weight. These findings suggested that while birth weight and being born 
SGA had no effect on incontinence, a low birth weight in combination with an elevated 
body mass index later in life may contribute to the risk of urinary incontinence. 
 
This is the first study that has evaluated the effect of birth characteristics, such as birth 
weight and being born SGA, on urinary incontinence. However, results from previous 
studies partially support our finding. Animal studies have shown that maternal 
nutritional restriction in early to mid-gestation impaired muscle development by 
affecting the number and composition of fibers in the offspring.89-92 Moreover, a human 
study reported that those born with a low birth weight have a different muscle fiber 
composition.88 Growth restriction may affect not only muscle composition but also 
muscle strength in humans.93-96 A study performed among college-aged women 
reported that women who had a low ponderal index have decreased muscle strength.97  
 
Being overweight or obese is a well-established risk factor for stress urinary 
incontinence, due to the increased intra-abdominal pressure associated with increasing 
body mass index. Thus, the combined effect of a low birth weight (and lower tissue 
resilience) and chronically elevated intra-abdominal pressure may adversely affect the 
intricate urethral sphincter complex and increase the risk for stress urinary 
incontinence.  
 
 
6.2 METHODOLOGICAL CONSIDERATIONS 
 
Study design 
 
All the four studies of this thesis are based on data from the STAGE survey. Self-
reported information regarding urinary incontinence subtypes was collected from the 
survey as well as information regarding most of the exposures and confounding 
variables that were used in the studies. 
 
Urinary incontinence symptoms were defined as an involuntary loss of urine that 
occurred in the month preceding the survey. However, there were no questions to 
determine when the urinary incontinence symptoms started: therefore it was not 
possible to determine whether the exposures preceded urinary incontinence or not. This 
problem affected Study I-III while in Study IV the exposures of interest (birth weight 
and being born small for gestational age) clearly occurred before the onset of urinary 
incontinence symptoms. 
 
In Study II, even though the diagnosis of gestational diabetes mellitus has occurred 
years before the survey, we could not entirely rule out the possibility that overactive 
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bladder symptoms started before the diagnosis of gestational diabetes mellitus. While it 
is implausible that overactive bladder may cause GDM, the inclusion of women who 
had overactive bladder symptoms before the diagnosis of gestational diabetes mellitus 
may have overestimated the effect of GDM on overactive bladder. The same problem 
was apparent in Study III since the definition of major depression in use was a lifetime 
assessment and there were no information regarding when this episode of depression 
has occurred, as well as the time of onset of incontinence. Therefore findings from 
these studies can be interpreted only in terms of association: the association observed 
could be determined by both the exposures causing incontinence or vice versa.  
 
The problem of not being able to determine if the exposure preceded incontinence or 
not affected also Study I, but the consequences on the association were different. While 
in Study II and III we may have overestimated the effect of the exposures on 
incontinence, in Study I we may have underestimated the effect of coffee and tea intake 
on urinary incontinence. The lack of association between coffee and tea consumption 
and incontinence can be determined by women that have decided to reduce their coffee 
and tea intake as a response to urinary incontinence. However, studies have shown that 
the proportion of women affected by incontinence that seek medical treatment is 
generally low2 and it is more likely that women reduce their overall fluid intake in 
response to incontinence rather than focusing on coffee and tea in specific.  
 
Information bias 
 
Information bias occurs when the exposure or the outcome of interest are measured or 
classified incorrectly.135 Misclassification can be of two types: differential or 
nondifferential. Differential misclassification refers to the situations in which the 
measurement of the exposure is dependent from the disease status or where the 
classification of the disease is related to the exposure: for example if the ascertainment 
of the exposure is more accurate among individuals who had the disease compared to 
healthy individuals. A particular case of differential misclassification is recall bias: this 
type of bias may affect a study if individuals with the disease had a better recall of their 
previous exposures compared to healthy individuals. When the misclassification of the 
exposure does not depend on the disease status, or vice versa, it is called nondifferential 
misclassification: in presence of nondifferential misclassification the exposure is 
misclassified equally among healthy subjects and individuals with the disease.  
 
Differential and nondifferential misclassifications have different effects on the 
association observed in a study. The presence of differential misclassification can either 
overestimates or underestimates the association, while the presence of nondifferential 
misclassification dilutes the association between exposure and disease when the 
exposure is binary. In case of exposures with three or more categories, the association 
for the intermediate category can be bias away from the null.136 
 
In epidemiological studies there always might be a risk for differential 
misclassification. However, due to the fact that the STAGE survey did not present the 
participants with specific a priori hypothesis and the questions on exposure and 
outcome did not follow each other during the survey, the misclassification may not be 
differential but rather nondifferential. 
   41 
 
Nondifferential misclassification was present to some extent in all four studies. In 
Study I women may have underreported or over reported their daily consumption of 
coffee and tea. In Study II women may not have reported the fact that they had a 
diagnosis of gestational diabetes mellitus. To minimize the exposure misclassification 
in Study II, the Medical Birth Register was utilized to identify women with a history of 
gestational diabetes mellitus who did not report GDM in the survey. Regarding Study 
III, women with depression may have decided to not respond to the questions contained 
in the section about depression, depressive symptoms, and neuroticism. Therefore, the 
prevalence of depression could have been underestimated but the level of 
misclassification should be the same among women with and without urinary 
incontinence. A possible source of misclassification in Study IV was that for like-sexed 
twin pairs their birth weight could have been mixed. To minimize this source of 
misclassification, the analysis was restricted only to twin pairs with known birth order: 
two algorithms were used to determine the birth order of all twin pairs enrolled in 
STAGE. However, both these two algorithms used self-reported birth weight that could 
be mistakenly reported by the study participants. 
 
Selection bias 
 
Selection bias is a distortion that may result from the procedures that have been used to 
select the study subjects or from the factors that influence the decision to participate in 
a study.135 A common consequence of selection bias is that the association between 
exposure and outcome observed among individuals enrolled in a study differs from the 
association among the individuals that were eligible. Since the general aim of the 
STAGE survey was to obtain information regarding several common complex diseases, 
and not urinary incontinence only, it is unlikely that women with incontinence were 
less willing, or more willing, to participate in the study. Moreover, the invitation letter 
was sent to all Swedish twins born between 1959 and 1985 with no exclusions.  
 
A previous study has shown that STAGE participants and non-participants did not 
differ by age, birth weight or whether they had been diagnosed with a neurological 
condition.137 However, compared with STAGE participants, a higher proportion of non-
participants were male, had at least one parent born outside of Sweden, had been 
convicted of any type of crime, were less educated, and had been diagnosed with a 
psychiatric disorder. Therefore it is possible that we may have underestimated the 
prevalence of depressive symptoms and major depression in Study III. 
 
Confounding/mediation analysis 
 
Confounding may be considered as a mixing of effects that distorts the association 
between exposure and outcome. A variable can be considered a confounder if it has the 
following three properties:  
 
1) It is a risk factor for the disease of interest or a surrogate for an actual cause of 
the disease 
2) It must be associated with the exposure 
3) It must not be affected by the exposure or the disease 
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The presence of a confounding variable can create an association between the exposure 
and the outcome even if neither is a cause of the other. Moreover, a confounder can 
also change the direction of an effect or lead to an overestimation or underestimation of 
the effect of the exposure. For these reasons it is necessary to adjust the analysis for a 
potential confounder in order to obtain an unbiased estimate of the effect of the 
exposure on the disease. In the four studies the analyses have been adjusted by all the 
factors that were potential risk factors for urinary incontinence, were associated with 
the exposure of interest, and were not a consequence of the exposure. 
 
A mediator variable is a consequence of the exposure that has an effect on the outcome 
of interest. To estimate the total causal effect of an exposure on a certain outcome it is 
not necessary to adjust for a mediator variable, but to estimate the direct effect, i.e. the 
effect that is not mediated by the mediator, the analysis must be adjusted for the 
mediator.  
 
 
 
 
 
 
However, adjusting for a mediator variable can introduce substantial bias if there is an 
unmeasured confounder between the mediator and the outcome.138 139  
 
 
 
 
 
 
 
In presence of an unmeasured confounding variable (U) between the mediator M and 
the outcome D, the total effect of the exposure on the outcome is not biased. However, 
adjusting for the mediator M will create a non-causal association between the exposure 
and the outcome. Therefore, the estimation of direct effects requires the absence of 
unmeasured confounding for both the effect of the exposure and the mediator on the 
outcome. 
 
In Study II and IV the analyses were adjusted for potential mediator variables: body 
mass index (Study II and IV) and diabetes mellitus (Study II). Moreover, in Study III 
we adjusted the analysis for use of antidepressant medications in the last month that 
could be both considered as a confounder or as a mediator variable. In fact women who 
had a diagnosis of major depression are more likely to take antidepressant medications 
E D 
C 
E D 
M 
E D 
M U 
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and women who are taking antidepressant medications are less likely to become 
depressed. Since in Study III we defined women with depression using a lifetime 
assessment, it is more likely that antidepressant medication mediates the effect of major 
depression on incontinence while confounds the effect of current depressive symptoms 
and neuroticism on urinary incontinence. 
 
Generalizability 
 
The study population in the four studies consisted of premenopausal Swedish female 
twins; therefore findings from these studies cannot for sure be generalized to other 
populations.  
 
First of all twins might differ from singletons regarding the occurrence of urinary 
incontinence and levels of exposures. While it is unlikely that twins have a different 
coffee and tea consumption compared to singletons, the prevalence of gestational 
diabetes mellitus observed among the women enrolled in STAGE (2.9%) is slightly 
higher compared to the prevalence reported in previous studies, where the prevalence 
ranged between 1.2-2.3%.140-143  However, the higher prevalence of GDM could be 
explained by individuals who mistakenly reported a diagnosis of gestational diabetes 
mellitus rather than GDM being more common among twins. Moreover, in Sweden 
there is no consensus regarding the screening and diagnostic of GDM. A previous study 
demonstrated that in a specific region of Sweden (Skåne) where all pregnant women 
are offered an oral glucose tolerance test, the prevalence of GDM is doubled compared 
to an adjacent geographical region using random glucose level measurements.143 
Therefore, the higher prevalence of GDM observed in STAGE could be explained by 
the fact that the proportion of women to whom was offered an oral glucose tolerance 
test to diagnose gestational diabetes mellitus was higher among the study participants 
than in the general population.  
 
In STAGE approximately eight percent of the women had major depression (7.9%), 
However, since it has been shown that STAGE non-participants had a higher 
prevalence of psychiatric disorders compared to the study participants,137 it is possible 
that we may have underestimated the prevalence of major depression. 
 
Twins usually have a lower birth weight and a shorter gestational age compared to 
singletons. However, a recent study has shown that there are no differences in mortality 
and morbidity between twins and singletons.144 Moreover, the prevalence of 
incontinence observed in STAGE is comparable to the one reported by a study 
conducted in Canada, Germany, Italy, Sweden, and the United Kingdom.145  
 
Since the Swedish population is mainly Caucasian, results from this thesis cannot be 
generalized to other ethnicities. In fact Black and Asian women have a substantially 
lower prevalence of incontinence compared to White women.2 Moreover, the 
prevalence of gestational diabetes mellitus in Sweden is much lower than in other 
countries/ethnicities.146 
 
Another problem in terms of generalizability is that women in these studies were 
premenopausal. In fact, the prevalence of urinary incontinence in premenopausal 
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women is lower than among postmenopausal women. Moreover, the effect of 
obstetrical factors such as gestational diabetes mellitus might be diluted among 
postmenopausal women because of ageing or hormonal changes.40 
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7 CONCLUSIONS 
 
• Coffee and tea consumption had little or no effect on lower urinary tract 
symptoms such as urinary incontinence, nocturia, and overactive bladder. A 
negative association was found between high coffee intake and overall 
incontinence, while a positive association was found between high tea 
consumption and nocturia and overactive bladder. However, after analyzing 
only discordant twin pairs, all these associations were found to be confounded 
by familial factors.  
 
• Women with a history of gestational diabetes mellitus had an approximately 
two times higher odds of overactive bladder compared to women without 
gestational diabetes mellitus. The effect of gestational diabetes mellitus on 
overactive bladder was not mediated by body mass index later in life or diabetes 
mellitus. Given the increasing prevalence of gestational diabetes mellitus in the 
past years, it is expected that in the future more women will be affected by 
overactive bladder because of gestational diabetes mellitus. 
 
• Depressive mood disorders (current depressive symptoms and major 
depression) and neuroticism were positively associated with urinary 
incontinence. However, the associations between depression and urge and 
mixed incontinence were confounded by neuroticism. A modest genetic 
correlation was found between depressive mood disorders and overall, as well 
as stress, incontinence: however, part of the variance that these traits shared due 
to genetic causes was also in common with neuroticism. Moreover, all the 
variance that was shared between depressive mood disorders and urge, or 
mixed, incontinence was completely in common with neuroticism. These 
findings suggest that genetic variants for neuroticism are largely driving the 
association between depressive mood disorders and incontinence. 
 
• Birth weight and being born small for gestational age had no effect on urinary 
incontinence. However, a statistically significant interaction was found between 
low birth weight and body mass index for overall and stress incontinence. 
Women who are overweight or obese and had a low birth weight had a 
borderline statistically significant higher odds of incontinence compared to 
overweight women who had a normal birth weight. Even though birth weight 
and being born small for gestational age had no effect on urinary incontinence, 
a low birth weight in combination with adult body mass index may contribute to 
the risk of urinary incontinence later in life.   
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